Orient Pharma Co., Ltd. (4166) Stock Statistics & Valuation Metrics
Total Valuation
Orient Pharma Co., Ltd. has a market cap or net worth of TWD 5.35B. The enterprise value is TWD 5.94B.
- Market Cap
- TWD 5.35B
- Enterprise Value
- TWD 5.94B
Share Statistics
Orient Pharma Co., Ltd. has 243,035,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 243,035,100
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Orient Pharma Co., Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 8.04%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.04%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 8.09M
- Profits Per Employee
- 1.20M
- Employee Count
- 173
- Asset Turnover
- 0.48
- Inventory Turnover
- 2.15
Valuation Ratios
The current PE Ratio of Orient Pharma Co., Ltd. is 23.33. Orient Pharma Co., Ltd.’s PEG ratio is 0.13.
- PE Ratio
- 23.33
- PS Ratio
- 3.70
- PB Ratio
- 2.07
- Price to FCF
- 27.85
- Price to Operating Cash Flow
- 18.90
- PEG Ratio
- 0.13
Income Statement
In the last 12 months, Orient Pharma Co., Ltd. had revenue of 1.40B and earned 208.44M in profits. Earnings per share was 0.90.
- Revenue
- 1.40B
- Gross Profit
- 706.92M
- Operating Income
- 261.06M
- Pretax Income
- 244.65M
- Net Income
- 208.44M
- EBITDA
- 396.67M
- Earnings Per Share (EPS)
- 0.90
Cash Flow
In the last 12 months, operating cash flow was 291.69M and capital expenditures -90.14M, giving a free cash flow of 201.55M billion.
- Operating Cash Flow
- 291.69M
- Free Cash Flow
- 201.55M
- Free Cash Flow per Share
- 0.84
Dividends & Yields
Orient Pharma Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.77%
- Earnings Yield
- 4.48%
Stock Price Statistics
- Beta
- 0.33
- 52-Week Price Change
- -11.29%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 25.15
- Average Volume (3m)
- 86.47K
Important Dates
Orient Pharma Co., Ltd. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Orient Pharma Co., Ltd. as a current ratio of 6.73, with Debt / Equity ratio of 7.64%
- Current Ratio
- 6.73
- Quick Ratio
- 5.01
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.99
- Interest Coverage Ratio
- 33.01
Taxes
In the past 12 months, Orient Pharma Co., Ltd. has paid 36.21M in taxes.
- Income Tax
- 36.21M
- Effective Tax Rate
- 0.15
Enterprise Valuation
Orient Pharma Co., Ltd. EV to EBITDA ratio is 12.80, with an EV/FCF ratio of 24.62.
- EV to Sales
- 3.27
- EV to EBITDA
- 12.80
- EV to Free Cash Flow
- 24.62
- EV to Operating Cash Flow
- 17.01
Balance Sheet
Orient Pharma Co., Ltd. has TWD 585.05M in cash and marketable securities with TWD 189.61M in debt, giving a net cash position of TWD 395.44M billion.
- Cash & Marketable Securities
- TWD 585.05M
- Total Debt
- TWD 189.61M
- Net Cash
- TWD 395.44M
- Net Cash Per Share
- TWD 1.63
- Tangible Book Value Per Share
- TWD 9.53
Margins
Gross margin is 54.86%, with operating margin of 18.39%, and net profit margin of 15.52%.
- Gross Margin
- 54.86%
- Operating Margin
- 18.39%
- Pretax Margin
- 18.89%
- Net Profit Margin
- 15.52%
- EBITDA Margin
- 25.56%
- EBIT Margin
- 18.88%
